Bayer

BAYN · Xetra · EUR

€44.94−1.01%−€0.46

Close · October 2, 2026

At a glance

Revenue growth: −2.21%; 2025 vs 2024
Net margin: -7.9%; 2024: -5.5%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	10,872	13,405	11,438	9,660	10,739	13,738	11,729	9,968	11,144	13,765	11,862	10,342
Cost of revenue	4,519	5,232	4,231	4,307	4,726	5,625	5,284	5,090	4,915	5,463	4,424	4,812
Gross profit	6,353	8,173	7,207	5,353	6,013	8,113	6,445	4,878	6,229	8,302	7,438	5,530
Selling, general and administrative	3,944	3,696	5,366	3,405	3,766	3,707	5,161	3,725	3,791	3,828	4,661	3,604
Research and development	1,507	1,419	1,286	1,498	1,502	1,458	1,490	1,559	1,459	1,426	1,069	1,502
Operating income	999	3,528	3,319	-543	994	2,324	3,320	-3,822	1,015	3,092	8,612	-3,594
EBIT	999	3,528	3,319	-543	994	2,324	3,320	-3,822	1,015	3,092	8,612	-3,594
EBITDA	2,157	4,761	4,725	412	1,266	3,472	3,888	-2,878	2,036	4,179	9,671	-2,689
Interest expense	81.0	474	527	539	62.0	473	560	451	117	407	395	467
Pre-tax income	321	2,989	-3,372	-1,161	-426	1,830	-481	-4,347	-97.0	2,591	1,644	-4,297
Income tax	92.0	222	378	-202	-236	526	-153	-153	-71.0	589	302	280
Net income	219	2,763	-3,757	-963	-199	1,299	-335	-4,183	-34.0	2,000	1,337	-4,569
Net income to common shareholders	219	2,763	-3,757	-963	-199	1,299	-335	-4,183	-34.0	2,000	1,337	-4,569
Basic EPS	0.22	2.81	-3.82	-0.98	-0.20	1.32	-0.34	-4.26	-0.03	2.04	1.36	-4.65
Diluted EPS	0.22	2.81	-3.82	-0.98	-0.20	1.32	-0.34	-4.26	-0.03	2.04	1.36	-4.65
Average shares (basic)	982	982	982	982	982	982	982	982	982	982	982	982
Average shares (diluted)	982	982	982	982	982	982	982	982	982	982	982	982
Dividend per share	—	—	0.11	—	—	—	0.11	—	—	—	0.11	—